NCT06101030

Brief Summary

This study is designed to determine if patients using an incentive spirometer with visual and auditory signals will increase their use of the incentive spirometer and prevent lung complications.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 25, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 16, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2025

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 7, 2025

Completed
Last Updated

April 10, 2025

Status Verified

April 1, 2025

Enrollment Period

1.6 years

First QC Date

October 18, 2023

Last Update Submit

April 7, 2025

Conditions

Keywords

Incentive spirometryPost Operativecompliance

Outcome Measures

Primary Outcomes (2)

  • Number of successful inspiratory breaths attempts per day.

    successful inspiratory breaths is defined as achieving the goal tidal volume

    through hospitalization an average of 5 days

  • Total number of inspiratory breaths achieved per day.

    Inspiratory breaths while using the incentive spirometer

    throughout hospitalization an average of 5 days

Secondary Outcomes (8)

  • Time to achieve goal tidal volume.

    throughout hospitalization an average of 5 days

  • Post operative length of O2 use.

    throughout hospitalization an average of 5 days

  • Change in 02 flow rate.

    throughout hospitalization an average of 5 days

  • inpatient Pulmonary complication rates.

    throughout hospitalization an average of 5 days

  • Hospital discharge on O2.

    throughout hospitalization an average of 5 days

  • +3 more secondary outcomes

Other Outcomes (5)

  • Intubation due to a respiratory diagnosis

    throughout hospitalization an average of 5 days

  • Reintubation due to a respiratory diagnosis

    throughout hospitalization an average of 5 days

  • ICU length of stay

    throughout hospitalization an average of 5 days

  • +2 more other outcomes

Study Arms (2)

Signal On

Patient Signals ON

Device: Signal On

Signal Off

Patient Signals Off

Interventions

Signal OnDEVICE

InSee monitor patient signals are on.

Signal On

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Post Operative Inpatients prescribed incentive spirometry.

You may qualify if:

  • Patient has undergone a qualifying surgical procedure.
  • Patient is aged 18 years or over.
  • Patient has incentive spirometry ordered or incentive spirometry must be part of the study site's standard of care which is implemented by hospital staff.
  • Patient is able to comply with all study required incentive spirometry instructions.
  • Patient is without severe hearing or impaired visual acuity deficiency such that they cannot hear or see the audible and visual signal for the InSee monitor.

You may not qualify if:

  • Vulnerable Populations (Pregnant, minors, prisoners, those with significantly reduced mental acuity).
  • Patients where incentive spirometry is inappropriate (patients with Tractotomy, patients who are hemodynamically unstable, patients in reverse isolation due to infection).
  • Patients with a history of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction), or cognitive issue which would in the opinion of the investigator, make it difficult for the patient to comply with the study procedures or follow the investigators instructions.
  • Any medical condition that, in the opinion of the investigator, would place the patient at increased risk if they participated.
  • Any Physician determination that the patient should not participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Tidal Reseach Site

Silver Spring, Maryland, 20904, United States

TERMINATED

Tidal Study Site

Rochester, Minnesota, 55905, United States

RECRUITING

Tidal Study Site

New Brunswick, New Jersey, 08901, United States

RECRUITING

Related Publications (3)

  • Eltorai AEM, Baird GL, Eltorai AS, Pangborn J, Antoci V Jr, Cullen HA, Paquette K, Connors K, Barbaria J, Smeals KJ, Agarwal S, Healey TT, Ventetuolo CE, Sellke FW, Daniels AH. Incentive Spirometry Adherence: A National Survey of Provider Perspectives. Respir Care. 2018 May;63(5):532-537. doi: 10.4187/respcare.05882. Epub 2018 Jan 23.

    PMID: 29362219BACKGROUND
  • Sweity EM, Alkaissi AA, Othman W, Salahat A. Preoperative incentive spirometry for preventing postoperative pulmonary complications in patients undergoing coronary artery bypass graft surgery: a prospective, randomized controlled trial. J Cardiothorac Surg. 2021 Aug 24;16(1):241. doi: 10.1186/s13019-021-01628-2.

    PMID: 34429138BACKGROUND
  • Alwekhyan SA, Alshraideh JA, Yousef KM, Hayajneh F. Nurse-guided incentive spirometry use and postoperative pulmonary complications among cardiac surgery patients: A randomized controlled trial. Int J Nurs Pract. 2022 Apr;28(2):e13023. doi: 10.1111/ijn.13023. Epub 2021 Oct 22.

    PMID: 34676618BACKGROUND

MeSH Terms

Conditions

Patient Compliance

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Hassan Study Director, M.D.

    Tidal Medical Technologies

    STUDY DIRECTOR

Central Study Contacts

Michael Martin, RN

CONTACT

Mehdi Arani

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2023

First Posted

October 25, 2023

Study Start

January 16, 2024

Primary Completion

September 3, 2025

Study Completion

September 7, 2025

Last Updated

April 10, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations